Search
for
Sort by
Research 61–90 of 251
- The impact of SARS-CoV-2 and COVID-19 on male reproduction and men’s health
- Clomipramine suppresses ACE2-mediated SARS-CoV-2 entry
- The impact of certain genetic variants (single nucleotide polymorphisms) on incidence and severity of COVID‐19
- Antiandrogens as Therapies for COVID-19: A Systematic Review
- Evaluation of SARS-CoV-2 Entry, Inflammation and New Therapeutics in Human Lung Tissue Cells
- Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Alopecia and grey hair are associated with COVID‐19 Severity
- Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity
- COVID‐19, androgens, and androgenic alopecia
- Proxalutamide Reduction of Mortality Rate in Hospitalized COVID-19 Patients Depends on Treatment Duration – an Exploratory Analysis of the Proxa-Rescue AndroCoV Trial
- Effects of 5‐alpha reductase inhibitors on lung function: A reason for discontinuation duringCOVID‐19 pandemic?
- Correlation Between Nongenomic Action of C19-Steroids and COVID-19 Severity
- Comment on “Androgens and women: COVID‐19 outcomes in women with acne vulgaris, polycystic ovarian syndrome, and hirsutism”
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- Androgen deprivation therapy and hormonal status in men with COVID-19
- In response to the letter to the editor by Soha Ghanian et al. re our publication “Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males”
- Editor’s picks January 2021
- Recommendations on trichological treatments during COVID-19 pandemic
- Tracing the cellular origin of cancer
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- Androgen receptor modulators: a review of recent patents and reports (2012-2018)
- COVID-19 and andrology: Recommendations of the French-speaking society of andrology (Société d’Andrologie de langue Française SALF)
- Androgens in SARS-CoV-2 Coronavirus Infections
- Associations between sun sensitive pigmentary genes and serum prostate specific antigen levels
- The significance of coronavirus infection in the development of reproductive and lower urinary tract lesions
- Anti-proliferative effect of terpenes on human prostate cáncer cells: natural sources and their potential role as chemopreventive agents.
- Evaluation of COVID-19 risk in patients on systemic retinoid therapy